Clinical Trials on Tumor Responses
Total 20299 results
-
Advanced Accelerator ApplicationsCompletedCarcinoid Tumor of the Small Bowel | Neuroendocrine TumourUnited States, United Kingdom, Italy, Belgium, France, Germany, Portugal, Spain
-
University of MichiganEnrolling by invitationCellular Responses Within Skeletal Muscle in Response to Exercise of Different Intensities | Relationship Between the Cellular Responses in Skeletal Muscle and the Changes in the Metabolomic Profile | Changes Within Adipose Tissue in Response to Exercise at the Three Different IntensitiesUnited States
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
University Medical Center GoettingenRecruitingPelvic Tumor | Thoracic TumorGermany
-
Elpiscience Biopharma, Ltd.Active, not recruitingNeoplasms | Solid Tumors | Malignant TumorChina
-
Elpiscience Biopharma, Ltd.TerminatedNeoplasms | Solid Tumors | Malignant TumorChina
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityCompletedAcute Toxic Effects | Tumor ResponsesChina
-
Roswell Park Cancer InstituteNeuroEndocrine Tumor Research Foundation (NETRF)RecruitingLung Atypical Carcinoid Tumor | Metastatic Pancreatic Neuroendocrine Tumor | Lung Typical Carcinoid TumorUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Dana-Farber Cancer InstituteBayer; NovartisCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
Aristotle University Of ThessalonikiCompletedPoor Ovarian Response | Androgen Receptor Gene Overexpression | Normal Responders | Bologna Criteria
-
Vanquish Oncology, Inc.University of Illinois at ChicagoCompletedSolid Tumor | Neuroendocrine Tumors | Pancreatic Neuroendocrine TumorUnited States
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
Georgetown UniversityImmune System Key LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsChina
-
National Cancer Institute (NCI)RecruitingMetastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2United States, Canada
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedMetastatic, Cerebral Primitive Neuroectodermal TumorsFrance
-
NantCell, Inc.CompletedSarcoma | Ewing's Sarcoma | Primitive Neuroectodermal Tumors (PNETs) | Askin's Tumors | Desmoplastic Small Round Cell Tumors | Estraosseous Ewing's Tumor | Ewing's Family Tumor
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Puerto Rico
-
MapKure, LLCRecruitingSolid Tumor | B-Raf Mutation-Related TumorsUnited States, Australia
-
Fujian Cosunter Pharmaceutical Co. LtdUnknownSolid Tumor | C-Met Mutation-Related TumorsChina
-
Keystone Nano, IncNational Cancer Institute (NCI); National Institutes of Health (NIH)UnknownCarcinoma | Cancer | Solid Tumors | TumorUnited States
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
University of California, San FranciscoPeterson Family FoundationTerminatedNeuroendocrine Tumor | Neuroblastoma | Paraganglioma | Carcinoid TumorsUnited States
-
Seattle Children's HospitalActive, not recruitingGlioma | Ependymoma | Medulloblastoma | Pineoblastoma | Central Nervous System Tumor, Pediatric | Germ Cell Tumor | Atypical Teratoid/Rhabdoid Tumor | Primitive Neuroectodermal Tumor | Choroid Plexus CarcinomaUnited States
-
Seattle Children's HospitalActive, not recruitingGlioma | Ependymoma | Medulloblastoma | Pineoblastoma | Central Nervous System Tumor, Pediatric | Germ Cell Tumor | Atypical Teratoid/Rhabdoid Tumor | Primitive Neuroectodermal Tumor | Choroid Plexus CarcinomaUnited States
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Children's Cancer and Leukaemia GroupUnknownBrain and Central Nervous System TumorsUnited Kingdom, Ireland
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingSolid Tumor | Metastatic Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Solid Carcinoma | Metastatic TumorUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMedulloblastoma | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor | Anaplastic Medulloblastoma | Supratentorial Embryonal Tumor, Not Otherwise SpecifiedUnited States, Canada, Australia, Puerto Rico
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Dana-Farber Cancer InstituteCompletedCarcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Yusuf MendaNational Cancer Institute (NCI); Holden Comprehensive Cancer Center; Perspective...Enrolling by invitationNeuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
David BushnellNational Cancer Institute (NCI); National Institutes of Health (NIH); Holden...Active, not recruitingNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting | Neuroendocrine Tumor, MalignantUnited States
-
AC Camargo Cancer CenterH. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingNeuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive TumorUnited States, Brazil
-
Jean M. Tersak, M.D.PfizerNo longer availableInflammatory Myofibroblastic Tumour
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Australia
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | Extragonadal Germ Cell Tumor | Pediatric Germ Cell TumorUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUntreated Childhood Medulloblastoma | Untreated Childhood Supratentorial Primitive Neuroectodermal TumorUnited States
-
Burzynski Research InstituteTerminatedPrimitive Neuroectodermal TumorUnited States
-
Centre Leon BerardTransgeneCompletedAdvanced Tumor | Metastatic TumorFrance
-
Eli Lilly and CompanyChildren's Oncology GroupCompletedRecurrent Tumor | Pediatric Solid Tumor | Refractory Tumor | CNS MalignanciesUnited States
-
Universitätsklinikum Hamburg-EppendorfCompletedBrain and Central Nervous System TumorsGermany
-
Children's Hospital Los AngelesNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Canada
-
Peter AndersonCompletedMetastatic Neuroendocrine Tumor | Recurrent Neuroendocrine TumorUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedBrain Tumor | Head and Neck Tumor | Skull Base TumorUnited States